Related Experiment Videos
Gastrointestinal lymphoma. A case for primary surgical resection
M S Talamonti1, L G Dawes, R J Joehl
1Department of Surgery, Northwestern University Medical School, Chicago, IL 60611.
Archives of Surgery (Chicago, Ill. : 1960)
|August 1, 1990
Summary
For primary gastrointestinal lymphoma, surgical resection before other treatments significantly improves survival rates, especially for localized disease. Early surgical intervention can prevent severe complications in advanced stages.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Oncology
Background:
- Primary gastrointestinal lymphoma is a rare malignancy.
- Treatment strategies vary, impacting patient outcomes.
- Optimal sequencing of therapies remains a key consideration.
Purpose of the Study:
- To compare the risks and outcomes of different primary treatment modalities for gastrointestinal lymphoma.
- To evaluate the impact of surgical resection timing on survival and complications.
Main Methods:
- Retrospective review of 42 consecutive patients with primary gastrointestinal lymphoma.
- Analysis of treatment modalities including surgical resection, radiation therapy, and chemotherapy.
- Comparison of 5-year survival rates based on treatment approach and disease stage.
Main Results:
- For localized disease (Stages I-II), 5-year survival was 82% with resection vs. 50% with radiation therapy.
- For disseminated disease (Stages III-IV), 5-year survival was 81% with resection followed by chemotherapy vs. 6% with radiation and chemotherapy.
- Five patients not undergoing resection before other therapies developed severe, life-threatening complications.
Conclusions:
- Surgical resection prior to other therapies is recommended for eligible gastrointestinal lymphoma patients.
- Early surgical intervention improves survival and reduces the risk of severe complications.
- Treatment decisions should prioritize surgical candidacy and tumor resectability.